A total of 20,149 Jan Aushadhi Kendras had been opened across the country as on 30 June 2026 under the PMBJP.
Sales of Rs 7,873.85 crore between 2021-22 and 2025-26 produced savings of about Rs 37,200 crore for citizens.
The product basket covers 2,110 medicines and 315 surgicals, consumables and devices.
Generic medicines at these kendras are typically 50% to 80% cheaper than branded equivalents.
Out-of-pocket expenditure as a share of total health expenditure fell from 62.6% in 2014-15 to 43.4% in 2022-23.
A generic medicine contains the same active ingredient, in the same strength and dosage form, as the branded product it copies, and must meet the same regulatory standards. What it does not carry is the originator's development cost or the marketing spend built into a brand's price. That is the entire source of the 50% to 80% price gap at a Jan Aushadhi Kendra — not a difference in the drug. The resistance to generics in India has historically been a trust problem rather than a price problem, which is why the scheme's quality architecture matters as much as its pricing: procurement only from WHO-GMP certified manufacturers, testing of 100% of batches before dispatch, and testing only at NABL-accredited laboratories that PMBI itself assesses for Good Laboratory Practices.
Simple Analogy: The same medicine without the advertising budget attached to the price tag.
The instrument under which drug prices are regulated, promulgated on the principles of the National Pharmaceutical Pricing Policy, 2012
Lists the scheduled formulations for which the NPPA fixes ceiling prices, binding on all manufacturers
Defines a 'new drug', for which the NPPA fixes a retail price applicable to the applicant manufacturer and marketer
A manufacturer may set the price freely but cannot raise the MRP by more than 10% during the preceding twelve months
Fixes ceiling prices of scheduled formulations and retail prices of new drugs, and monitors compliance with DPCO 2013 including overcharging
Implementing agency for PMBJP — procurement, quality assurance, warehousing and distribution to kendras
State-level units that feed the NPPA information on prices and violations
Health assurance for secondary and tertiary hospitalisation
Key: Cover of Rs 5 lakh per family per year, including for medicines; run by the Department of Health and Family Welfare
Provide essential medicines free at public health facilities
Key: Operates under the National Health Mission, covering facilities from Primary Health Centres to district hospitals, based on the essential medicines list recommended under Indian Public Health Standards
Discounted medicines and implants for cancer, cardiovascular and other diseases
Key: AMRIT Pharmacy stores in hospitals offer an average discount of up to 50% on market rates
Financial assistance to below-poverty-line patients with major life-threatening diseases
Key: Covers conditions including cancer for patients from BPL families
GS Paper 2 > Governance > Health Schemes and Issues Relating to Health
General Awareness > Government Schemes
General Awareness > Schemes and Social Sector
Which of the following statements is/are true of the Fundamental Duties of an Indian citizen? 1. A legislative process has been provided to enforce these duties. 2. They are correlative to legal duties. Select the correct answer using the code given below:
Answer: Neither 1 nor 2
Jan Aushadhi and drug price control are near-certain topics in banking and SSC General Awareness and recur in UPSC GS Paper 2.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana — the scheme providing quality generic medicines through Jan Aushadhi Kendras
National Pharmaceutical Pricing Authority — fixes ceiling prices under DPCO 2013 and acts against overcharging
Drugs (Prices Control) Order, 2013, based on the National Pharmaceutical Pricing Policy, 2012
Health spending paid directly by households at the point of care, the mechanism by which illness causes impoverishment
World Health Organization Good Manufacturing Practices — the certification required of manufacturers supplying Jan Aushadhi medicines